Primary Aldosteronism and Cerebrovascular Diseases

被引:26
作者
Chen, Zheng-Wei [1 ,2 ]
Hung, Chi-Sheng [1 ]
Wu, Vin-Cent [1 ]
Lin, Yen-Hung [1 ]
机构
[1] Natl Taiwan Univ Coll Med, Natl Taiwan Univ Hosp, Dept Internal Med, 7 Chung Shan South Rd, Taipei 100, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Internal Med, Yun Lin Branch, Yunlin, Taiwan
关键词
Primary aldosteronism; Cerebrovascular disorders; Stroke; INTIMA-MEDIA THICKNESS; ARTERIAL STIFFNESS; ATRIAL-FIBRILLATION; CARDIOVASCULAR EVENTS; STROKE; RISK; PREVALENCE; DIAGNOSIS; SPIRONOLACTONE; HYPERTENSION;
D O I
10.3803/EnM.2018.33.4.429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As diagnostic techniques have advanced, primary aldosteronism (PA) has emerged as the most common cause of secondary hypertension. The excess of aldosterone caused by PA resulted in not only cardiovascular complications, including coronary artery disease, myocardial infarction, arrhythmia. and heart failure, but also cerebrovascular complications, such as stroke and transient ischemic attack. Moreover, PA is associated more closely with these conditions than is essential hypertension. In this review, we present up-to-date findings on the association between PA and cerebrovascular diseases.
引用
收藏
页码:429 / 434
页数:6
相关论文
共 47 条
[1]   Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism (Conn's syndrome) [J].
Aloul, Basel Al. ;
Li, Jian-Ming ;
Benditt, David ;
Tholakanahalli, Venkatakrishna .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2006, 29 (11) :1303-1305
[2]   Prevention of aortic fibrosis by spironolactone in spontaneously hypertensive rats [J].
Benetos, A ;
Lacolley, P ;
Safar, ME .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1152-1156
[3]   Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism [J].
Bernini, Giampaolo ;
Galetta, Fabio ;
Franzoni, Ferdinando ;
Bardini, Michele ;
Taurino, Chiara ;
Bernardini, Melania ;
Ghiadoni, Lorenzo ;
Bernini, Matteo ;
Santoro, Gino ;
Salvetti, Antonio .
JOURNAL OF HYPERTENSION, 2008, 26 (12) :2399-2405
[4]   Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited A Population-Based Study [J].
Bjorck, Staffan ;
Palaszewski, Bo ;
Friberg, Leif ;
Bergfeldt, Lennart .
STROKE, 2013, 44 (11) :3103-3108
[5]   Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients [J].
Blacher, J ;
Asmar, R ;
Djane, S ;
London, GM ;
Safar, ME .
HYPERTENSION, 1999, 33 (05) :1111-1117
[6]   Vascular Actions of Aldosterone [J].
Briet, Marie ;
Schiffrin, Ernesto L. .
JOURNAL OF VASCULAR RESEARCH, 2013, 50 (02) :89-99
[7]   Eplerenone - Cardiovascular protection [J].
Brown, NJ .
CIRCULATION, 2003, 107 (19) :2512-2518
[8]  
Calò LA, 2005, KIDNEY INT, V68, P1899
[9]   Cardiovascular outcomes in patients with primary aldosteronism after treatment [J].
Catena, Cristiana ;
Colussi, GianLuca ;
Nadalini, Elisa ;
Chiuch, Alessandra ;
Baroselli, Sara ;
Lapenna, Roberta ;
Sechi, Leonardo A. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) :80-85
[10]   Global Burden of Stroke [J].
Feigin, Valery L. ;
Norrving, Bo ;
Mensah, George A. .
CIRCULATION RESEARCH, 2017, 120 (03) :439-448